Methods Adults ( 18 years old) in a US claims database with a claim indicating initiation of either semaglutide or a DPP4i (index date) during the index period (1 January 201830 September 2020), a diagnosis code for T2D on or before the index date and at least 12 months continuous enrolment in the database pre-index were included and propensity score matched 1:1 on baseline demographic and clinical characteristics
Do not let your total daily calories drop so low that your body has no choice but to consume muscle for fuel
GLP-1 receptor agonists are well known for promoting weight loss and improving glycemic control, but scientists are increasingly examining how these medications influence muscle health Read More
How much does blood sugar typically drop on semaglutide
One should not use AOD-9604 if they: Are pregnant or breastfeeding Are a minor Have a current or recent history of cancer (particularly hormone-sensitive cancers) Have uncontrolled diabetes or significant insulin resistance Have active thyroid disease that is not well-managed Are taking medications that may interact with peptide therapy (discuss with your provider) Have a known hypersensitivity to peptide compounds Comprehensive labs including metabolic panel, fasting glucose, HbA1c, thyroid panel, lipid panel, and hormone levels should be run before starting any peptide therapy and monitored regularly throughout
